Archer-Daniels-Midland Company (ADM) Analyst Ratings & Price Targets

Archer-Daniels-Midland Company

ADM · NYSE

Analyst Consensus

Hold

15 analysts

$86

Current

—

Low

$85

Average

—

High

Average target implies -1.67% versus the current price.

Analyst Ratings Synthesis

Consensus is Underperform, backed by all 15 analysts in the supplied summary. The only stated target statistic is a mean of $77; low and high targets are unavailable, so neither a target cluster nor the width of the range can be measured. The evidence does not identify which named analyst or firm is most bullish or least bullish, and it supplies no attributable target revisions during the past week. The substantive basis for the negative consensus is therefore not specified in the analyst data. Against that cautious stance, ADM reported a 29.58% earnings surprise, a 1.37% revenue surprise and a raised FY2026 outlook, creating a clear debate over whether the Q2 improvement is durable enough to change expectations.

Rating Actions

No individual rating actions have been captured for ADMyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Research Reports

Links to freely available third-party research. Outlook labels are our classification of each article's stance, not a rating of our own.

Covering Firms

ARGUS RESEARCH

B OF A GLBL RES

BAIRD R W

BARCLAYS CAPITA

BMO CAPITAL MKT

CO FORECST

GOLDMAN SACHS

JEFFERIES & CO.

JP MORGAN SECUR

MORGAN STANLEY

ROTH CAPITAL PA

STEPHENS INC

STIFEL NICOLAUS

UBS

ZACKS RESEARCH

Symbol: ADM
Type: Stock
Sector: Consumer Staples
Industry: Fats & Oils
Exchange: NYSE

ADM unlocks the power of nature to enrich the quality of life. We're an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. We're a premier human and animal nutrition provider, offering one of the industry's broadest portfolios of ingredients and solutions from nature. We're a trailblazer in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. We're a cutting-edge innovator, guiding the way to a future of new bio-based consumer and industrial solutions. And we're leading in business-driven sustainability efforts that support a strong agricultural sector, resilient supply chains, and a vast and growing bioeconomy. Around the globe, our expertise and innovation are meeting critical needs from harvest to home.

Key Issues

Bullish view

The second quarter delivered an earnings surprise of 29.58%, with adjusted earnings nearly doubling as oilseeds, ethanol and Nutrition improved. ADM also raised its 2026 outlook, supporting the case that the recovery extends beyond one quarter.

Bearish view

The evidence identifies a single strong quarter but does not establish that gains in crushing, ethanol and Nutrition will persist. The company’s FY2025 net income was already below FY2024, leaving room for skepticism about earnings durability.

Analyst Consensus

See all

Hold

15 analysts

$86

Current

—

Low

$85

Average

—

High

Average target implies -1.67% versus the current price.

Earnings History

BeatMissNo estimate

Archer-Daniels-Midland Company

Analyst Consensus

Analyst Ratings Synthesis

Rating Actions

Research Reports

Covering Firms

Peers